These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
Source ↗
👁 0
💬 0
Biotechs aimed at eye diseases, autoimmune conditions and longevity medicine have pulled in some of the largest capital raises so far this year.
Comments (0)